PT  - JOURNAL ARTICLE
AU  - Zhang, Jianguo
AU  - Ding, Daoyin
AU  - Cao, Can
AU  - Zhang, Jinhui
AU  - Huang, Xing
AU  - Fu, Peiwen
AU  - Liang, Guoxin
AU  - Xu, Wenrong
AU  - Tao, Zhimin
TI  - Myocardial characteristics as the prognosis for COVID-19 patients
AID  - 10.1101/2020.05.06.20068882
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.06.20068882
4099  - http://medrxiv.org/content/early/2020/05/09/2020.05.06.20068882.short
4100  - http://medrxiv.org/content/early/2020/05/09/2020.05.06.20068882.full
AB  - Background Amid the crisis of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), front-line clinicians in collaboration with backstage medical researchers analyzed clinical characteristics of COVID-19 patients and reported the prognosis using myocardial data records upon hospitalization.Methods We reported 135 cases of laboratory-confirmed COVID-19 patients admitted in The First People’s Hospital of Jiangxia District in Wuhan, China. Demographic data, medical history, and laboratory parameters were taken from inpatient records and compared between patients at the Intensive Care Unit (ICU) and non-ICU isolation wards for prognosis on disease severity. In particular, survivors and non-survivors upon ICU admission were compared for prognosis on disease mortality.Results For COVID-19 patients, blood test results showed more significantly deranged values in the ICU group than those in non-ICU. Among those parameters for ICU patients, myocardial variables including troponin T, creatine kinase isoenzymes, myoglobin, were found significantly higher in non-survivors than in survivors.Conclusions Upon hospitalization abnormal myocardial metabolism in COVID-19 patients could be prognostic indicators of a worsened outcome for disease severity and mortality.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a single-centered, retrospective, and observational study without trial registration.Funding StatementJiangsu Province Professorship, Jiangsu University Jinshan Professorship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData access will be provided upon request once approved.